Stay updated on Miransertib in Overgrowth Spectrum Clinical Trial

Sign up to get notified when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Miransertib in Overgrowth Spectrum Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:51:11.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A notice at the top of the page announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T14:28:30.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:16:31.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:24:29.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    A 403 error page is now displayed in place of the study details, masking the MOSAIC study information and navigation.
    Difference
    20%
    Check dated 2026-09-21T20:39:31.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    - Revision: v3.6.6 replaces v3.6.5 on the page, signaling a minor platform update. This change does not modify study details or user-facing study information.
    Difference
    0.0%
    Check dated 2026-08-31T17:46:52.000Z thumbnail image

Stay in the know with updates to Miransertib in Overgrowth Spectrum Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.